Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IGC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 5
35 filers reported a long position in IGC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $239.2K | 879.4K | -15.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $221.7K | 814.9K | +13.4% |
| BlackRock, Inc. | $191.4K | 703.8K | Unchanged |
| AdvisorShares Investments LLC | $184.5K | 678.5K | New |
| CITADEL ADVISORS LLC | $119K | 437.3K | New |
| VANGUARD FIDUCIARY TRUST CO | $114.1K | 419.4K | +0.8% |
| RENAISSANCE TECHNOLOGIES LLC | $78K | 286.6K | -40.8% |
| STATE STREET CORP | $54.6K | 200.8K | Unchanged |
| NORTHERN TRUST CORP | $46.3K | 170.3K | +50.1% |
| LAWOOD & CO | $20.4K | 75K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.